Institutionalizing Health Technology Assessment and Priority Setting in South Korea's Universal Health Coverage Journey.

Health technology assessment Korea health technology reassessment priority setting public participation universal health coverage

Journal

Health systems and reform
ISSN: 2328-8620
Titre abrégé: Health Syst Reform
Pays: United States
ID NLM: 101697320

Informations de publication

Date de publication:
31 Dec 2023
Historique:
medline: 8 5 2024
pubmed: 8 5 2024
entrez: 8 5 2024
Statut: ppublish

Résumé

This study charts the chronological developments of the three institutions that were established in South Korea for priority setting in health. In 2007, the Evidence-based Medicine Team and the Center for New Health Technology Assessment (CnHTA) were established and nested in the Health Insurance Review and Assessment Service (HIRA). In December 2008, the National Evidence-based Healthcare Collaborating Agency (NECA) was launched, to which the CnHTA was transferred in 2010. Since then, non-drug technologies have been reviewed by NECA and drugs have been reviewed by HIRA. Political debates about how to embrace expensive but important health technologies that were not on the benefits list led to the creation of the Participatory Priority Setting Committee (PPSC) in 2012. The PPSC, led by the general public, has played a key role in advancing the path toward universal health coverage by revitalizing the list of essential, yet previously overlooked, medical technologies. PPSC offers these technologies a second chance at coverage. HIRA and NECA served to strengthen evidence-based and efficiency-based decision-making in the health system via CnHTA, and PPSC served to strengthen social value-based decision making via priority setting in Korea. The reassessment by PPSC may be relevant in countries where the economy is growing and citizens want to rapidly expand the benefits list.

Identifiants

pubmed: 38715186
doi: 10.1080/23288604.2024.2338308
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2338308

Auteurs

Juhwan Oh (J)

Department of Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.

Min-Jeong Kim (MJ)

Division of Health Technology Assessment Research, National Evidence-Based Healthcare Collaborating Agency, Seoul, Republic of Korea.

Sujeong Hur (S)

Dongdaemoon Branch Office, National Health Insurance Service, Seoul, Republic of Korea.

Juyeon Oh (J)

Payment System Assessment Division, Health Insurance Review and Assessment Service, Wonju, Republic of Korea.

Dong-Sook Kim (DS)

Department of Health Administration, Kongju National University College of Nursing and Health, Kongju, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH